Rhythm Pharmaceuticals annual depreciation and amortization
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Rhythm Pharmaceuticals Depreciation & Amortization Growth & History (RYTM)
Rhythm Pharmaceuticals's depreciation and amortization was $500,000 for fiscal 2025.
View full Rhythm Pharmaceuticals company overviewRhythm Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $500,000 | −$200,000 | −28.57% |
| 2024 | 2024-12-31 | $700,000 | −$200,000 | −22.22% |
| 2023 | 2023-12-31 | $900,000 | $4,000 | +0.45% |
| 2022 | 2022-12-31 | $896,000 | $80,000 | +9.80% |
| 2021 | 2021-12-31 | $816,000 | $126,000 | +18.26% |
| 2020 | 2020-12-31 | $690,000 | −$144,000 | −17.27% |
| 2019 | 2019-12-31 | $834,000 | $392,000 | +88.69% |
| 2018 | 2018-12-31 | $442,000 | $219,000 | +98.21% |
| 2017 | 2017-12-31 | $223,000 | $79,000 | +54.86% |
| 2016 | 2016-12-31 | $144,000 | — | — |
Rhythm Pharmaceuticals quarterly depreciation and amortization
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $251,000 | −$128,000 | −33.77% |
| Q1 2026 | 2026-03-31 | $252,000 | — | — |
| Q4 2025 | 2025-12-31 | $272,000 | — | — |
| Q3 2025 | 2025-09-30 | $304,000 | — | — |
| Q2 2025 | 2025-06-30 | $379,000 | — | — |
| Q3 2021 | 2021-09-30 | $315,000 | $143,000 | +83.14% |
| Q2 2021 | 2021-06-30 | $317,000 | $144,000 | +83.24% |
| Q1 2021 | 2021-03-31 | $201,000 | $34,000 | +20.36% |
| Q3 2020 | 2020-09-30 | $172,000 | −$19,000 | −9.95% |
| Q2 2020 | 2020-06-30 | $173,000 | −$34,000 | −16.43% |
| Q1 2020 | 2020-03-31 | $167,000 | −$78,000 | −31.84% |
| Q3 2019 | 2019-09-30 | $191,000 | $85,000 | +80.19% |
| Q2 2019 | 2019-06-30 | $207,000 | $146,000 | +239.34% |
| Q1 2019 | 2019-03-31 | $245,000 | $184,000 | +301.64% |
| Q3 2018 | 2018-09-30 | $106,000 | $51,000 | +92.73% |
| Q2 2018 | 2018-06-30 | $61,000 | $7,000 | +12.96% |
| Q1 2018 | 2018-03-31 | $61,000 | $7,000 | +12.96% |
| Q3 2017 | 2017-09-30 | $55,000 | — | — |
| Q2 2017 | 2017-06-30 | $54,000 | — | — |
| Q1 2017 | 2017-03-31 | $54,000 | — | — |
Rhythm Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Rhythm Pharmaceuticals's depreciation and amortization decreased from $690,000 to $500,000, a change of −$190,000. The latest reported quarter, Q2 2026, shows $251,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rhythm Pharmaceuticals source filings ↗